B-lymphoblastoid_JJ
cell_NN
lines_NNS
from_IN
multiple_JJ
sclerosis_NN
patients_NNS
and_CC
a_DT
healthy_JJ
control_NN
producing_VBG
a_DT
putative_JJ
new_JJ
human_JJ
retrovirus_NN
and_CC
Epstein-Barr_JJ
virus_NN
._.

On_IN
several_JJ
occasions_NNS
we_PRP
have_VBP
observed_VBN
retrovirus-like_JJ
particles_NNS
-LRB-_-LRB-
RVLPs_NNS
-RRB-_-RRB-
by_IN
transmission_NN
electron_NN
microscopy_NN
-LRB-_-LRB-
EM_NN
-RRB-_-RRB-
of_IN
cultured_VBN
T_NN
cells_NNS
from_IN
a_DT
patient_NN
with_IN
MS_NN
._.

Later_RB
we_PRP
established_VBD
spontaneously_RB
formed_VBN
B-lymphoblastoid_JJ
cell_NN
lines_NNS
-LRB-_-LRB-
LCLs_NNS
-RRB-_-RRB-
from_IN
a_DT
patient_NN
with_IN
an_DT
MS-like_JJ
disease_NN
and_CC
from_IN
another_DT
patient_NN
with_IN
MS_NN
who_WP
had_VBD
a_DT
reactivated_VBN
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
infection_NN
._.

Both_DT
LCLs_NNS
were_VBD
found_VBN
by_IN
EM_NN
to_TO
produce_VB
RVLP_NN
and_CC
EBV_NN
particles_NNS
._.

Reverse_JJ
transcriptase_NN
-LRB-_-LRB-
RT_NN
-RRB-_-RRB-
assays_NNS
were_VBD
positive_JJ
in_IN
purified_VBN
viral_JJ
material_NN
from_IN
both_DT
LCLs_NNS
._.

To_TO
substantiate_VB
these_DT
findings_NNS
we_PRP
initiated_VBD
an_DT
intensified_VBN
culturing_NN
procedure_NN
and_CC
were_VBD
able_JJ
to_TO
establish_VB
LCLs_NNS
from_IN
5_CD
out_IN
of_IN
21_CD
consecutive_JJ
MS_NN
patients_NNS
and_CC
1_CD
out_IN
of_IN
13_CD
consecutive_JJ
healthy_JJ
controls_NNS
._.

All_DT
LCLs_NNS
were_VBD
found_VBN
to_TO
produce_VB
both_CC
RVLP_NN
and_CC
EBV_NN
particles_NNS
by_IN
EM_NN
._.

Whether_IN
the_DT
putative_JJ
new_JJ
retrovirus_NN
-LRB-_-LRB-
es_NNS
-RRB-_-RRB-
and_CC
EBV_NN
have_VBP
any_DT
causal_JJ
relationship_NN
to_TO
MS_NN
is_VBZ
still_RB
not_RB
known_VBN
,_,
but_CC
the_DT
findings_NNS
support_VBP
this_DT
possibility_NN
._.

